Research Overview
Tirzepatide is a novel dual GIP/GLP-1 receptor agonist (twincretin) that activates both glucose-dependent insulinotropic polypeptide receptor (GIPR) and GLP-1R. In vitro research applications include dual incretin receptor pharmacology, comparative receptor binding studies, metabolic signaling pathway analysis, and insulin secretion models. Among the most studied dual agonist compounds in metabolic research.
Compound Specifications
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
|---|---|
| Molecular Weight | 4,813.5 Da |
| CAS Number | 2023788-19-2 |
| Sequence | Tyr-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys(C20 fatty diacid)-Ile-Ala-Gln-Gln-Ala-Arg-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH₂ |
| Purity | >98% (HPLC verified) |
| Storage | Store at -20°C. Stable 24 months lyophilized. |
| Form | Lyophilized powder |
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
Certificate of Analysis
Each batch is third-party tested. COA available upon request — contact us with your order number.


Reviews
There are no reviews yet.